Studies on the mutagenic activity of hydralazine and dihydralazine in Salmonella typhimurium strains differing in expression of antioxidant genes.
Toxicol Lett
; 110(3): 203-7, 1999 Nov 22.
Article
en En
| MEDLINE
| ID: mdl-10597029
The mutagenic activity of two antihypertensive drugs, hydralazine and dihydralazine was investigated in oxyR- proficient (TA104) and -deficient (TA4125) Salmonella typhimurium strains showing different ability to induce proteins involved in protection of the cells against oxidative damage. The results of the Ames test demonstrated that dihydralazine, in contrast to hydralazine, was mutagenic for oxyR- strain at concentrations that were nonmutagenic for oxyR+ strain. The scavenger of superoxide anion, superoxide dismutase decreased in both strains the number of revertants induced by dihydralazine but not by hydralazine. The results may suggest that active oxygen species generated by dihydralazine contribute to its mutagenicity.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Proteínas Represoras
/
Salmonella typhimurium
/
Factores de Transcripción
/
Dihidralazina
/
Proteínas de Unión al ADN
/
Hidralazina
/
Mutágenos
/
Antihipertensivos
Idioma:
En
Revista:
Toxicol Lett
Año:
1999
Tipo del documento:
Article
País de afiliación:
Polonia
Pais de publicación:
Países Bajos